Jennifer J. Rhodes J.D.
Net Worth

Last updated:

What is Jennifer J. Rhodes J.D. net worth?

The estimated net worth of Ms. Jennifer J. Rhodes J.D. is at least $2,062,428 as of 14 Dec 2021. She has earned $62,428 from insider trading and has received compensation worth at least $2,000,000 in Angion Biomedica Corp..

What is the salary of Jennifer J. Rhodes J.D.?

Ms. Jennifer J. Rhodes J.D. salary is $500,000 per year as Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec. in Angion Biomedica Corp..

How old is Jennifer J. Rhodes J.D.?

Ms. Jennifer J. Rhodes J.D. is 55 years old, born in 1970.

What stocks does Jennifer J. Rhodes J.D. currently own?

As insider, Ms. Jennifer J. Rhodes J.D. owns shares in one company:

Company Title Shares Price per share Total value
Angion Biomedica Corp. (ANGN) Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec. 30,399 $0 $0

What does Angion Biomedica Corp. do?

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.

ANGN logo
ANGN
Angion Biomedica Corp.

Jennifer J. Rhodes J.D. insider trading

Angion Biomedica Corp.

Ms. Jennifer J. Rhodes J.D. has made 12 insider trades in 2021, according to the Form 4 filled with the SEC. Most recently she sold 451 units of ANGN stock worth $1,090 on 14 Dec 2021.

The largest trade she's ever made was exercising 499 units of ANGN stock on 13 Mar 2021. As of 14 Dec 2021 she still owns at least 30,399 units of ANGN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 451 $2.42 $1,090
Sale
Common Stock 433 $4.4 $1,905
Sale
Common Stock 430 $8.65 $3,720
Sale
Common Stock 430 $10.64 $4,575
Sale
Common Stock 445 $10.68 $4,753
Sale
Common Stock 432 $10.94 $4,726
Sale
Common Stock 431 $11.01 $4,745
Sale
Common Stock 427 $13.27 $5,666
Sale
Common Stock 440 $13.92 $6,125
Sale
Common Stock 399 $15.01 $5,989
Sale
Common Stock 499 $20.45 $10,205
Sale
Common Stock 457 $19.54 $8,930

Angion Biomedica Corp. key executives

Angion Biomedica Corp. executives and other stock owners filed with the SEC:

  • Dr. Jay R. Venkatesan M.B.A., M.D., Ph.D. (53) Pres, Chief Executive Officer & Director
  • Mr. Gregory S. Curhan (63) Interim Chief Financial Officer
  • Ms. Jennifer J. Rhodes J.D. (55) Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.